Literatur
-
1
Altman J, Moss P AH, Gouldre P, Barouch D, McHeyzer-Williams M, Bell J I, McMichael A J, Davis M M.
Direct visualization
and phenotypic analysis of virus-specific T lymphocytes in HIV-infected
individuals.
Science.
1996;
274
94-96
-
2
Boel P, Wildmann C, Sensi M L, Brasseur R, Renauld J C, Coulie P, Boon T, Van der Bruggen P.
BAGE,
a new gene encoding an antigen recognized on human melanomas by
cytolytic T lymphocytes.
Immunity.
1995;
2
167-175
-
3
Chen Y -T, Scanlan M J, Sahin U, Türeci Ö, Gure A O, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old L J.
A testicular antigen aberrantly
expressed in human cancers detected by autologous antibody screening.
Proc
Nat Acad Sci USA.
1997;
94
1914-1918
-
4
Coulie P G, Brichard V, Van Pel A, Wölfel T, Schneider J, Traversari C, Mattei S, DePlaen E, Lurquin C, Szikora J -P, Renauld J -C, Boon T.
A new gene coding for a
differentiation antigen recognized by autologous cytolytic T lymphocytes
on HLA-A2 melanomas.
J Exp Med.
1994;
180
35-42
-
5
Coulie P G, Lehmann F, Lethe B, Herman J, Lurquin C, Andrawiss M, Boon T.
A
mutated intron sequence codes for an antigenic peptide recognized
by cytolytic T lymphocytes on a human melanoma.
Proc Natl
Acad Sci USA.
1995;
92
7976-7980
-
6
Czerkinsky C, Andersson G, Ekre H -P, Nilsson L -A, Klareskog L, Ouchterlony Ö.
Reverse
ELISPOT assay for clonal anlysis of cytokine production.
J
Immunol Methods.
1988;
110
29-36
-
7
Disis M L, Cheever M A.
Oncogenic
proteins as tumor antigens.
Current Opinion in Immunology.
1996;
8
637-642
-
8
Dranoff G, Jaffee E, Lazenbry A, Golumbek P, Levitsky H, Brose K, Jeckson V, Hamada H, Pardoll D, Mulligan R.
Vaccination with irradiated
tumor cells engineered to secrete murine granulocyte-macrophage
colony-stimulating factor stimulates potent, specific, and long-lasting
anti-tumor immunity.
Proc Natl Acad Sci USA.
1993;
90
3539-3543
-
9
Herin M, Lemoine C, Weynants P, Vessiere F, VanPel A, Knuth A, Devos R, Boon T.
Production of stable cytolytic
T cell clones directed against autologous human melanoma.
Int
J Cancer.
1987;
39
390-396
-
10
Hsu F J, Caspar C B, Czerwinski D, Kwak L W, Liles T M, Syrengelas A, Taidi-Laskowski B, Levy R.
Tumor-specific idiotype
vaccines in the treatment of patients with B-cell lymphoma - long
term results of a clinical trial.
Blood.
1997;
89
3129-3135
-
11
Jäger D, Stockert E, Güre A O, Scanlan M J, Karbach J, Jäger E, Knuth A, Old L J, Chen Y -T.
Identification
of a tissue-specific putative transcription factor in breast tissue
by serological screening of a breast cancer library.
Cancer
Res.
2001;
61
2055-2061
-
12
Jäger E, Arand M, Ringhoffer M, Karbach J, Jäger D, Ilsemann C, Hagedorn M, Oesch F, Knuth A.
Cytolytic
T cell reactivity against melanoma associated differentiation antigens
in in pepripheral blood of melanoma patients and healthy individuals.
Melanoma
Research.
1996;
6
419-425
-
13
Jäger E, Bernhard H, Romero P, Ringhoffer M, Arand M, Karbach J, Ilsemann C, Hagedorn M, Knuth A.
Generation
of cytotoxic T cell responses with synthetic melanoma associated
peptides in vivo: implications for tumor vaccines with melanoma
associated antigens.
Int J Cancer.
1996;
66
162-169
-
14
Jäger E, Gnjatic S, Stockert E, Nagata Y, Jäger D, Karbach J, Neumann A, Rieckenberg J, Chen Y -T, Ritter G, Hoffman E, Arand M, Old L J, Knuth A.
Induction of primary NY-ESO-1
immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated
patients with NY-ESO-1+ cancers.
Proc Natl Acad
Sci, USA.
2000;
97
12 198-12 203
-
15
Jäger E, Maeurer M, Höhn H, Karbach J, Jäger D, Zidianakis Z, Bakhshandeh-Bath A, Orth J, Neukirch C, Necker A, Reichert T E, Knuth A.
Clonal expansion of Melan
A-specific cytotoxic T lymphocytes (CTL) in a melanoma patient responding
to continued immunization with melanoma-associated peptides.
Int
J Cancer.
2000;
86
538-547
-
16
Jäger E, Nagata Y, Gnjatic S, Wada H, Stockert E, Karbach J, Dunbar P R, Lee S Y, Jungbluth A, Jäger D, Arand M, Ritter G, Cerundolo V, Dupont B, Chen Y T, Old L J, Knuth A.
Monitoring
CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular
immune responses [In Process Citation].
Proc
Natl Acad Sci USA.
2000;
97
4760-4765
-
17
Jäger E, Ringhoffer M, Dienes H -P, Arand M, Karbach J, Jäger D, Ilsemann C, Hagedorn M, Oesch F, Knuth A.
Granulocyte macrophage colony-stimulating
factor enhances immune responses to melanoma associated peptides
in vivo.
Int J Cancer.
1996;
67
54-62
-
18
Jäger E, Ringhoffer M, Karbach J, Arand M, Oesch F, Jäger D, Knuth A.
Immunoselection in vivo:
Independent loss of MHC class I and melanocyte differentiation antigen
expression in metastatic melanoma mediated by antigen-specific CTL.
Int
J Cancer.
1997;
71
142-147
-
19
Knuth A, Danowski B, Oettgen H F, Old L J.
T-cell-mediated
cytotoxicity against autologous malignant melanoma: analysis with
interleukin-2-dependent T-cell cultures.
Proc Natl Acad
Sci.
1984;
81
3511-3515
-
20
Kugler A, Stuhler G, Walden P, Zöller G, Zobywalski A, Brossart P, Trefzer U, Ullrich S, Müller C A, Becker V, Gross A J, Hemmerlein B, Kanz L, Müller G A, Ringert R -H.
Regression
of human metastatic renal cell carcinoma after vaccination with
tumor cell-dendritic cell hybrids.
Nat Med.
2000;
6
332-336
-
21
Marchand M, van Baren N, Weynants P, Brichard V, Dreno B, Tessier M -H, Rankin E, Parmiani G, Arienti F, Humblet Y, Bourlond A, Vanwijck R, Lienard D, Beauduin M, Dietrich P -Y, Russo V, Kerger J, Masucci G, Jäger E, De Greve J, Atzpodien J, Brasseur F, Coulie P, van der Bruggen P, Boon T.
Tumor regressions observed
in patients with metastatic melanoma treated with an antigenic peptide
encoded by gene MAGE-3 and presented by HLA-A1.
Int J
Cancer.
1998;
80
219-230
-
22
Matzinger P.
Tolerance,
danger, and the extended family.
Ann Rev Immunol.
1994;
12
991-1045
-
23
Mukherji B, Chakraborty N G, Yamasaki S, Okino T, Yamase H, Sporn J R, Kurtzman S K, Ergin M T, Ozols J, Meehan J, Mauri F.
Induction
of antigen-specific cytolytic T cells in situ in human melanoma
by immunization with synthetic peptide-pulsed autologous antigen
presenting cells.
Proc Natl Acad Sci USA.
1995;
92
8078-8082
-
24
Mukherji B, MacAlister T J.
Clonal
analysis of cytotoxic T cell response against human melanoma.
J
Exp Med.
1983;
158
240-244
-
25
Rosenberg S A.
Development
of cancer immunotherapies based on identification of the genes encoding
cancer regression antigens.
J Natl Cancer Inst.
1996;
88
1635-1644
-
26
Thurner B, Haendle I, Roder C, Dieckmann D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, von den Driesch P, Brocker E B, Steinman R M, Enk A, Kampgen E, Schuler G.
Vaccination
with MAGE-3A1 peptide-pulsed mature, monocyte-derived dendritic cells
expands specific cytotoxic T cells and induces regression of some
metastases in advanced stage IV melanoma.
J Exp Med.
1999;
190
1669-1678
-
27
Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S, Boon T.
A new family of genes coding
for an antigen recognized by autologous cytolytic T lymphocytes
on a human melanoma.
J Exp Med.
1995;
182
689-698
-
28
Van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T.
A gene encoding an antigen
recognized by cytolytic T lymphocytes on a human melanoma.
Science.
1991;
254
1643-1647
-
29
Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, DePlaen E, Hankeln T, Meyer zum Büschenfelde K -H, Beach D.
A
p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes
in a human melanoma.
Science.
1995;
269
1281-1284
-
30
Wölfel T, Van Pel A, Brichard V, Schneider J, Seliger B, Meyer zum Büschenfelde K -H, Boon T.
Two tyrosinase nonapeptides
recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes.
Eur
J Immunol.
1994;
24
759-764
-
31
Zinkernagel R M, Doherty P C.
MHC-restricted
cytotoxic cells. Studies on the biological role of polymorphic major
transplantation antigens determining T-cell restriction-specificity,
function and responsiveness.
Advanc Immunol.
1979;
27
51
Korrespondenz
PD Dr. med. Elke Jäger
II. Medizinische Klinik, Hämatologie - Onkologie, Krankenhaus
Nordwest
Steinbacher Hohl 2-26
60488 Frankfurt
Phone: 069/7601-3319
Fax: 069/769932
Email: EJ200161@aol.com
